CDX
Health Care Equipment & Services
Cardiex
- Short interest
- 0.02%
- +0.02 pp 30d
- as of 24 Jan 2025
- Reported shorts
- 66.7K
- Shares on issue
- 405.231M
Cardiex (CDX) company profile
Profile, insiders and operations
Company
AI-generated research profile of Cardiex
Health Care Equipment
Cardiovascular Health
Medical Devices
Patient Assessment
ASX
Cardiex Limited (CDX) specializes in the development and marketing of the SphygmoCor device, a proprietary technology designed for advanced cardiovascular patient assessment and management. This device focuses on measuring central blood pressure and arterial stiffness, offering a more comprehensive view of cardiovascular health than traditional cuff-based measurements. The company aims to provide clinicians with tools to improve diagnostic accuracy and personalize treatment strategies for cardiovascular conditions.
Director trades
15 trades recorded
CDX intelligence dossier
Public-source evidence for this company, with industry drill-up links.
- Tax paid and taxable income records
- Government contracts and public money
- Emissions and trade exposure
- Political donations and lobbying links
Sign in to unlock the dossierFree account · no card required